Reduction of fasting blood glucose and hemoglobin A1C using oral aloe vera: A meta-analysis

Journal of Alternative and Complementary Medicine

Volumn 22, Issue 6, 2016, Pages 450-457

  Dick, William R ^a   Fletcher, Emily A ^a   Shah, Sachin A ^a,b  

^a DAVID GRANT MEDICAL CENTER   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOE VERA EXTRACT; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; PLANT EXTRACT;

ALOE VERA; ARTICLE; DIABETES MELLITUS; DIET RESTRICTION; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; META ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; ALOE; CHEMISTRY; DRUG EFFECTS; PHYTOTHERAPY;

ALOE; BLOOD GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84975317598     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2015.0122     Document Type: Article

References (47)

1. World Diabetes Foundation. Annual Review 2013. Online document at: http://worldiabetesfoundation.org/stories/annual-review-2013. Accessed August 19, 2014.
2. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2014. Online document at: http://www.cdc.gov//diabetes/pubs/statsreport14/nationaldiabetes-report-web.pdf. Accessed August 18, 2014.
3. Gupta R, Bajpai KG, John S, Saxena AM. An overview of Indian novel traditional medicinal plants with antidiabetic potentials. Afr J Trod Comp Alt Med 2008; 5: 1-17.
4. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes ResClin Pract 2010; 87: 1-19.
5. American Diabetes Association. Economic costs of diabetics in the US in 2012. Diabetes Care 2013; 36: 1033-1046.
6. International Diabetes Federation. IDF Diabetes Atlas, sixth edition. Online document at: http://idf.org/diabetesatlas/economic-impacts-diabetes. Accessed August 19, 2014.
7. Ngo MQ, Nguyen NN, Shah SA. Oral aloe vera for treatment of diabetes mellitus and dyslipidemia. Am J Health Syst Pharm 2010; 67: 1804, 1806, 1808.
8. Lee T, Dugoua JJ. Nutritional supplements and their effect on glucose control. Adv Exp Med Biol 2012; 771: 381-395.
9. Surjushe A, Vasani R, Saple DG. Aloe vera: a short review. Indian J Dermatol 2008; 53: 163-166.
10. The International Aloe Science Council. IASC aloe vera FAQ, version 1.0. Online document at: http://www.iasc.org/faq.html. Accessed January 26, 2015.
11. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines. A Guide for Health-Care Professionals. London: The Pharmaceutical Press, 1996.
12. Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999; 49: 823-828.
13. Ulbricht C, Armstrong J, Basch E, et al. An evidence-based systematic review of aloe vera by the Natural Standard Research Collaboration. JHerb Pharmacother 2007; 7: 279-323.
14. Nagarajan S, Jain HC, Aulakh GS. Indigenous plants used in the control of diabetes. In: Cultivation and Utilization of Medicinal Plants. Atal CK, Kapureds BM, eds, Jammutawi, India: Regional Research Laboratory, Council of Scientific and Industrial Research, 1982: 584-604.
15. Yeh GY, Eisenburg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003; 26: 1277-1294.
16. Choudhary M, Kochar A, Sangha J. Hypoglycemic and hypolipidemic effect of Aloe vera L. in non-insulin dependent diabetics. J Food Sci Tecnol 2014; 51: 90-96.
17. Yagi A, Hegazy S, Kabbash A, Wahab EA. Possible hypoglycemic effect of Aloe vera L. high molecular weight fractions on type 2 diabetic patients. Saudi Pharm J. 2009; 17: -209-215.
18. Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine 1996; 3: -241-243.
19. Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 1996; 3: -245-248.
20. Devaraj S, Yimam M, Brownell LA, Jialal I, Singh S, Jia Q. Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome. Metab Syndr Relat Disord. 2013 11 35-40.
21. Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Med. 2012; 78: 311-316.
22. Choi HC, Kim SJ, Son KY, Oh BJ, Cho BL. Metabolic effects of aloe vera gel complex in obese prediabetes and early non-treated diabetic patients: randomized controlled trial. Nutrition 2013; 29: 1110-1114.
23. Ghannam N, Kingston M, Al-Meshaal IA, et al. The antidiabetic activity of aloes: preliminary clinical and experimental observations. Horm Res 1986; 24: 288-294.
24. Arora D, Goyal M, Agarwal RP. Efficacy of Aloe vera juice consumption on glycemic response in Type-2 diabetic patients. Int J Food Sci Tech. 2009; 46: 160-162.
25. Al-Awadi FM, Gumaa KA. Studies on the activity of individual plants of an antidiabetic mixture. Acta Diabetol Lat 1987; 24: 37-41.
26. Tanaka M, Misawa E, Ito Y, et al. Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol Pharm Bull 2006; 29: 1418-1422.
27. Rajasekaran S, Ravi K, Sivagnanam K et al. Beneficial effects of Aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clin Exp Pharmacol Physiol 2006; 33: 232-237.
28. Kim K, Kim H, Kwon J, et al. Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine 2009; 16: 856-863.
29. Perez YY, Jimenes-Ferrer E, Zamilpa A, et al. Effect of a polyphenol-rich extract from Aloe vera gel on experimentally induced insulin resistance in mice. Am J Chin Med 2007; 35: 1037-1046.
30. Ajabnoor M.A. Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. J Ethnopharmacol 1990; 28: 215-220.
31. Al-Awadi F, Fatania H, Shamte U. The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabetes Res 1991; 18: 163-168.
32. Misawa E, Tanaka M, Nomaguchi K, et al. Oral ingestion of aloe vera phytosterols alters hepatic gene expression profiles and ameliorates obesity-Associated metabolic disorders in Zucker diabetic fatty rats. J Agric Food Chem 2012; 60: 2799-2806.
33. Shin E, Shin S, Kong H, et al. Dietary aloe reduces adipogenesis via the activation of AMPK and suppresses obesity-related inflammation in obese mice. Immune Netw 2011; 11: 107-113.
34. Atherton P. Aloe vera revisited. Br J Phytother 1998; 4: 176-183.
35. Shelton RM. Aloe vera: its chemical and therapeutic properties. Int J Dermatol 1991; 30: 679-683.
36. Rajendran A, Narayanan V, Gnanavel I. Study on the analysis of trace elements in Aloe vera and its biological importance. J Appl Sci Res 2007; 3: 1476-1478.
37. Shah AH, Qureshi S, Tariq M, Ageel AM. Toxicity studies on six plants used in the traditional Arab system of medicine. Phytother Res 1989; 3: 25-29.
38. Bottenburg MM, Wall GC, Harvey RL, et al. Oral aloe vera-induced hepatitis. Ann Pharmacother. 2007; 41: 1740-1743.
39. Rabe C, Musch A, Schirmacher P, et al. Acute hepatitis induced by an aloe vera preparation: a case report. World J Gastroenterol 2005; 11: 303-304.
40. Pigatto PD, Guzzi G. Aloe linked to thyroid dysfunction. Arch Med Res 2005; 36: 608.
41. Natural Medicines Comprehensive Database. Aloe monograph. Online document at: http://www.naturaldatabase .therapeuticresearch.com. Accessed February 1, 2015.
42. Aloecorp. GRAS status given to Qmatrix. Online documen at: http://www.aloecorp.com/news-release/gras-status-givenqmatrix. Accessed February 1, 2015.
43. Terry Laboratories. Terry laboratories receives GRAS status. Online document at: http://blog.terrylabs.com/2012/04/18/terry-laboratories-receives-gras-status/. Accessed February 1, 2015.
44. Natural Products Insider. Pharmachem Laboratories Inc. obtains GRAS status. Online documen at: http://www .naturalproductsinsider.com/News/2013/11/Pharmachem-Laboratories-Inc-Obtains-GRAS-Status.aspx?topic=aloe-vera. Accessed February 1, 2015.
45. The International Aloe Science Council. Certification Program. Online document at: http://www.iasc.org/certify .html. Accessed February 1, 2015.
46. Sakauye SD, Shah SA. Liraglutide: a human GLP-1 analogue for the treatment of type 2 diabetes. Formulary 2009; 44: 136-142.
47. Bergfield WF. Final report of the cosmetic ingredient review. Int J Toxicol 2007; 26: 1-50.